Purpose:To examine the ability of subcutaneously administered Octreotide (
a long acting somatostatin analogue) to serve as an inhibitory agent for co
rneal neovascularization in eyes of Wistar Albino rats.
Methods: Neovascular growth into the corneas of all the animals was induced
by silver nitrate cauterization. Half of the animals which were randomly s
elected for the Octreotide group received 30 micrograms systemic Octreotide
for 7 days. The treatment was initiated on the same day as chemical cauter
ization. The rest of the animals (control group) received no treatment. Sli
t lamp and histopathologic examination of the corneas of both groups were p
erformed at the end of the study period.
Results: It was observed that the corneal neovascularization and histopatol
ogic scores of the Octreotide group were significantly lower than those of
the control group (p<0.001, p<0.01).
Conclusion: Systemic administration of Octreotide inhibits the corneal neov
ascular response in a rat model.